Evoke plc (EVOK.L)
GBp 62.0
(-0.56%)
GBp 62.0
(-0.56%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 19.2 Million | -104.1 Million | 96.41 Million | 139.04 Million | 63.25 Million | 32.02 Million |
| Net Income | -56.4 Million | -120.5 Million | 50.09 Million | 8.81 Million | 32.6 Million | 71.09 Million |
| Depreciation & Amortization | 228.3 Million | 120.3 Million | 26.39 Million | 26.2 Million | 25.24 Million | 15.22 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | -500 Thousand | 5.2 Million | 6.1 Million | 8.07 Million | 4.07 Million | - |
| Change in working capital | -81.9 Million | -169.8 Million | -3.85 Million | 26.12 Million | 2.19 Million | -44.02 Million |
| Other non-cash items | 427.3 Million | 457.1 Million | 89.79 Million | 125.39 Million | 49.53 Million | 36.67 Million |
| Investing Cash Flow | -30.9 Million | -430.6 Million | -22.24 Million | -24.17 Million | -65.37 Million | -23.39 Million |
| Investments in PPE | -70.3 Million | -76.8 Million | -22.24 Million | -25.73 Million | -17.87 Million | -16.49 Million |
| Acquisitions | 24.5 Million | -386.3 Million | - | 1.46 Million | -47.5 Million | -6.89 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 19.2 Million | 32.5 Million | - | 1.55 Million | - | - |
| Other Investing Activities | -4.3 Million | -33.2 Million | -18.8 Million | -14.84 Million | -10.49 Million | - |
| Financing Cash Flow | -46.6 Million | 663.9 Million | -50.6 Million | -45.15 Million | -23.75 Million | -42.97 Million |
| Debt repayment | -4 Million | -527.6 Million | -5.2 Million | -14.03 Million | -13.71 Million | - |
| Dividends payments | - | - | -44.57 Million | -25.88 Million | -31.66 Million | -42.44 Million |
| Common Stock Repurchased | - | -700 Thousand | -799.82 Thousand | -233.94 Thousand | - | -599.96 Thousand |
| Common Stock Issuance | - | 158.5 Million | - | - | 78.38 Thousand | 74.99 Thousand |
| Other Financing Activities | -10.8 Million | -49.4 Million | -500 Thousand | -731.25 Thousand | -981.35 Thousand | - |
| Accounts receivables | -1.9 Million | -50.3 Million | -16.57 Million | -29.47 Million | -8.07 Million | 5.32 Million |
| Accounts payables | -39.6 Million | -100.3 Million | 3.34 Million | 34.38 Million | 12.22 Million | -21.82 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -40.4 Million | -19.2 Million | 9.37 Million | 21.21 Million | -1.95 Million | -27.52 Million |
| Cash at beginning of period | 339.2 Million | 195.72 Million | 141.33 Million | 75.1 Million | 104.42 Million | 132.76 Million |
| Cash at end of period | 278.8 Million | 339.2 Million | 195.72 Million | 141.33 Million | 75.1 Million | 104.42 Million |
| Capital Expenditure | -70.3 Million | -76.8 Million | -22.24 Million | -25.73 Million | -17.87 Million | -16.49 Million |
| Effect of forex changes on cash | -3.1 Million | -1 Million | 3.1 Million | 2.71 Million | -377.44 Thousand | - |
| Net cash flow / Change in cash | -60.4 Million | 143.47 Million | 54.38 Million | 66.22 Million | -29.31 Million | -28.33 Million |
| Free Cash Flow | -51.1 Million | -180.9 Million | 74.16 Million | 113.3 Million | 45.38 Million | 15.52 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -143.2 Million | -23.9 Million | -56.4 Million | -11.95 Million | -32.5 Million | -16.25 Million |
| Depreciation & Amortization | 111 Million | 121.9 Million | 228.3 Million | 15.35 Million | 106.4 Million | 53.2 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 350 Thousand | -500 Thousand | 350 Thousand | -600 Thousand | -600 Thousand |
| Change in working capital | 18 Million | -65.3 Million | -81.9 Million | -28.75 Million | -16.6 Million | 7.6 Million |
| Other non-cash items | 212.8 Million | 246.3 Million | 427.3 Million | 53.55 Million | 181 Million | 3.2 Million |
| Investing Cash Flow | -29.7 Million | -35.6 Million | -30.9 Million | -13.75 Million | 4.7 Million | 3.2 Million |
| Investments in PPE | -34.9 Million | -36.5 Million | -70.3 Million | -1.1 Million | -33.8 Million | -2.6 Million |
| Acquisitions | 2 Million | 2 Million | 24.5 Million | - | 22.5 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 19.2 Million | 19.2 Million | - | - | - |
| Other Investing Activities | 3.2 Million | -20.3 Million | -4.3 Million | -12.65 Million | 16 Million | 5.8 Million |
| Financing Cash Flow | 22.5 Million | -25.4 Million | -46.6 Million | -46.15 Million | -21.2 Million | -48.15 Million |
| Debt repayment | -41.5 Million | -2 Million | -4 Million | - | -2 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -19 Million | -10.8 Million | -10.8 Million | -46.15 Million | -48.15 Million | -48.15 Million |
| Accounts receivables | 8 Million | -29.1 Million | -1.9 Million | -14.55 Million | 27.2 Million | 13.6 Million |
| Accounts payables | 12.8 Million | -7.8 Million | -39.6 Million | - | -31.8 Million | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.8 Million | -28.4 Million | -40.4 Million | -14.2 Million | -12 Million | -6 Million |
| Cash at beginning of period | 278.8 Million | 318 Million | 339.2 Million | - | 339.2 Million | - |
| Cash at end of period | 243.6 Million | 278.8 Million | 278.8 Million | -30.9 Million | 318 Million | 200 Thousand |
| Capital Expenditure | -34.9 Million | -36.5 Million | -70.3 Million | -1.1 Million | -33.8 Million | -2.6 Million |
| Effect of forex changes on cash | - | 450 Thousand | -3.1 Million | 450 Thousand | -2 Million | -2 Million |
| Net cash flow / Change in cash | -35.2 Million | -39.2 Million | -60.4 Million | -30.9 Million | -21.2 Million | 200 Thousand |
| Free Cash Flow | -37.5 Million | -38.2 Million | -51.1 Million | 27.45 Million | -12.9 Million | 44.55 Million |
NGRD3
HVID
FNCNF
ABEV3
BRCR11
000623